Sage Journals: Discover world-class research

Abstract

Malignant syphilis is a rare skin manifestation of secondary syphilis, which has been reported primarily in the HIV-infected population. This study aimed to investigate the relationship between HIV infection, malignant syphilis, and neurosyphilis through a systematic chart review of 26 malignant syphilis patients seen at our hospital. We also performed a literature review of 83 reported malignant syphilis cases since 1987, when the first case of malignant syphilis co-infected with HIV was reported. We found there was no direct association between HIV infection and malignant syphilis or neurosyphilis. In contrast, we found that much higher proportion (30%) of malignant syphilis patients develop concurrent neurosyphilis compared to those with the common type of secondary syphilis (13.1%). Physicians should be aware of the fact that neurosyphilis is more common among patients with malignant syphilis and the importance of investigating for neurosyphilis in such patients.

Keywords

Malignant syphilis neurosyphilis HIV-negative

Get full access to this article

View all access options for this article.

References

Kumar

Muralidhar

Malignant syphilis: a review. AIDS Patient Care STDS 1998; 12: 921–925.

Sands

Markus

Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: case report and review. Clin Infect Dis 1995; 20: 387–390.

Tucker

Shah

Jarell

et al . Lues maligna in early HIV infection case report and review of the literature. Sex Transm Dis 2009; 36: 512–514.

Don

Rubinstein

Christie

Malignant syphilis (lues maligna) and concurrent infection with HIV. Int J Dermatol 1995; 34: 403–407.

National Health and Family Planning Commission of the People’s Republic of China. The national statutory epidemic situation of infectious diseases. 2014.

Rosenheim

Brucker

Leibowitch

et al . Malignant syphilis in a patient with anti-HIV antibodies. Presse Medicale (Paris, France: 1983) 1987; 16: 777.

Workowski

Berman

Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59: 1–110.

Chinese Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Shanghai: Shanghai Scientific & Technical Publisher, 2007.

Passoni

de Menezes

Ribeiro

et al . Lues maligna in an HIV-infected patient. Rev Soc Bras Med Trop 2005; 38: 181–184.

10.

Weis

Bonamigo

Weber

et al . Malignant syphilis and neurolues in an HIV infected patient. Int J Dermatol 2010; 49: 590–592.

11.

Pleimes

Hartschuh

Kutzner

et al . Malignant syphilis with ocular involvement and organism-depleted lesions. Clin Infect Dis 2009; 48: 83–85.

12.

Wang

A case of lues maligna in an AIDS patient. Int J STD AIDS 2012; 23: 599–600.

13.

Jalili

Mosleh

Grabmeier-Pfistershammer

et al . Malignant syphilis in a HIV infected patient. Sex Transm Dis 2015; 42: 223–225.

14.

De Socio

Simonetti

Tomasini

et al . Malignant syphilis with ocular involvement in an HIV-infected patient. Int J STD AIDS 2011; 22: 298–300.

15.

de Unamuno Bustos

Sanchez

Carazo

et al . Malignant syphilis with ocular involvement in an immunocompetent patient. Int J Dermatol 2014; 53: e258–e260.

16.

Yanagisawa

Ando

Imamura

et al . Pathologically confirmed malignant syphilis in an HIV-infected patient. Intern Med 2011; 50: 2423–2426.

17.

Marra

Maxwell

Smith

et al . Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189: 369–376.

18.

Libois

De Wit

Poll

et al . HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007; 34: 141–144.

19.

Perez-Perez

Cabanillas

Ginarte

et al . Malignant syphilis in an HIV-infected patient. Actas Dermosifiliogr 2007; 98: 351–354.

20.

Mohan

Ali

Isache

et al . Malignant syphilis: ostraceous, ulceronecrotic lesions in a patient with human immunodeficiency virus. Dermatol Online J 2017; 23.

21.

Cid

Cudos

Zamora Vargas

et al . Pathologically confirmed malignant syphilis using immunohistochemical staining: report of 3 cases and review of the literature. Sex Transm Dis 2014; 41: 94–97.

22.

Barros D'Elia Zanella

Facchini Lellis

Khoury

et al . Rupioid lesions, PLEVA and superposition phenomenon in malignant syphilis: two case reports in HIV-infected patients. J Eur Acad Dermatol Venereol 2018; 32: e91–e92.

23.

Glover

Piaquadio

Kern

et al . An unusual presentation of secondary syphilis in a patient with human immunodeficiency virus infection. A case report and review of the literature. Arch Dermatol 1992; 128: 530–534.

24.

Turchetti

Pacella

et al . An immunocompetent migrant presenting with neurosyphilis with an unusual unilateral papillitis: a case report. Eur J Med Res 2012; 17: 3.

25.

Hoang

High

Molberg

KH.

Secondary syphilis: a histologic and immunohistochemical evaluation. J Cutan Pathol 2004; 31: 595–599.

26.

Marra

CM.

Update on neurosyphilis. Curr Infect Dis Rep 2009; 11: 127–134.

27.

Ghanem

KG.

REVIEW: Neurosyphilis: a historical perspective and review. CNS Neurosci Ther 2010; 16: e157–e168.

28.

Workowski

Bolan

GA.

Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64: 1–137.

29.

Schofer

Imhof

Thoma-Greber

et al . Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med 1996; 72: 176–181.

30.

de Carvalho

Mello

Castro

et al . Malignant syphilis in an HIV seropositive woman. Int J Gynaecol Obstet 2008; 102: 297–298.

31.

MacDonald

Wong

Canadian guidelines on sexually transmitted infections, 2006. CMAJ 2007; 176: 175–176.

32.

French

Gomberg

Janier

et al . IUSTI: 2008 European Guidelines on the Management of Syphilis. Int J STD AIDS 2009; 20: 300–309.

33.

Shi

Peng

Gao

et al . Risk profiles of neurosyphilis in HIV-negative patients with primary, secondary and latent syphilis: implications for clinical intervention. J Eur Acad Dermatol Venereol 2016; 30: 659–666.

34.

Goldmeier

Hay

A review and update on adult syphilis, with particular reference to its treatment. Int J STD AIDS 1993; 4: 70–82.

35.

Zhou

et al . Re-evaluation of serological criteria for early syphilis treatment efficacy: progression to neurosyphilis despite therapy. Sex Transm Infect 2012; 88: 342–345.

36.

Drago

Ciccarese

Merlo

et al . Is the standard treatment for early syphilis sufficient to prevent cardiovascular and neurologic syphilis?. Am J Cardiol 2016; 117: 310–311.

37.

Drago

Ciccarese

Broccolo

et al . A new enhanced antibiotic treatment for early and late syphilis. J Glob Antimicrob Resist 2016; 5: 64–66.

38.

Drago

Ciccarese

Cinotti

et al . Screening, treatment, and follow-up of syphilis patients: issues, concerns and efforts to improve current paradigms. Indian J Sex Transm Dis 2015; 36: 112–114.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.07 MB

Neurosyphilis is more common in malignant syphilis: A case series and review of the literature

Abstract

Keywords

Get full access to this article

References

Supplementary Material